This databook provides a forecast and analysis of IT spending in the pharma/biotech industries through to 2013 in China. The sectors covered include big pharma, mid pharma, biotech, and small pharma/biotech.
Scope
- The databook provides forecasts relating to total pharmaceutical IT spending in China through to 2013
- In each sub-sector, pharmaceutical IT spending is segmented by hardware, software and services
- Contains pharmaceutical IT spending forecasts in China in relation to the wider region
Highlights of this title
The big pharma sector led the pharmaceutical IT spending in China accounting for 56.8% of the total IT spending in 2007.
Pharmaceutical IT spending in China is expected to increase at a compound annual growth rate (CAGR) of 12.1% over the 2008-13 period.
China accounted for 10.7% of the total pharmaceutical IT spending in Asia Pacific in 2007.
Key reasons to purchase this title
- Understand the opportunity for technology spending in the life science market
- Identify potential areas for spending growth amongst pharmaceutical and biotechnology companies
- Contains an analysis of pharmaceutical IT spending forecast by each sector in China
